GreyBird Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
9
- Portfolio
-
7
- Exits
-
1
GreyBird Ventures General Information
Company Description
Founded in 2013, GreyBird Ventures is a venture capital investment firm headquartered in Concord, Massachusetts. The firm seeks to invest in the medical technology, diagnostic technology, and precision healthcare sectors.
Business Details
Website
www.greybirdventures.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 31 Pond View Lane
- Concord, MA 01742
- United States
GreyBird Ventures Investments (9)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Genetika+ | 01-Nov-2021 | Early Stage VC | 0000 | Decision/Risk Analysis | Product Development | 00000 000000 |
| Platomics | 20-Sep-2021 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
| Angstrom | 04-Jun-2021 | 00000 00000 | 000 | Decision/Risk Analysis | Generating Revenue | 00000 000000 |
| GNA Biosolutions | 30-Aug-2019 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | 000000 00000 |
| Platomics | 06-Aug-2019 | 00000 00000 | Diagnostic Equipment | Generating Revenue | ||
| JF Intelligent Healthcare Technology | 15-Apr-2019 | 00000 00000 | 000 | Decision/Risk Analysis | Generating Revenue | |
| Ceres Nano | 30-May-2018 | 00000 00000 | 00.00 | Diagnostic Equipment | Generating Revenue | 000000 00000 |
| Atlas5D | 01-Feb-2016 | Later Stage VC | 000 | Monitoring Equipment | Generating Revenue | 00000 000000 |
| Hummingbird Diagnostics | 01-Jan-2016 | Later Stage VC | Diagnostic Equipment | Generating Revenue | 00000 000000 |
GreyBird Ventures Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| GNA Biosolutions | 05-Feb-2021 | 000000000000 |
GreyBird Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
GreyBird Ventures Management, Team & Partners (12)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Michael Devlin | Co-Founder & Managing Partner | 0 | 0 | 0 | Concord, MA |
| Thomas Miller | Co-Founder & Managing Partner | 0 | 0 | Concord, MA | |
| Scott Gazelle Ph.D | Co-Founder | 0 | 0 | Concord, MA | |
| Frank Wu | Advisors | Concord, MA | |||
| Stefan Herm | Advisors | Concord, MA |
GreyBird Ventures Co-Investors (6)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Hilltop Venture Partners | 1 | 0 |
|
|
|
| Howard Morgan | 0 | 0 |
|
|
|
| Jumpspeed Ventures | 0 | 0 |
|
|
|
| Meron Capital | 0 | 0 |
|
|
|
| Sapir Venture Partners | 0 | 0 |
|
|
GreyBird Ventures FAQs
-
What is GreyBird Ventures?
Founded in 2013, GreyBird Ventures is a venture capital investment firm headquartered in Concord, Massachusetts.
-
When was GreyBird Ventures founded?
GreyBird Ventures was founded in 2013.
-
Who is the founder of GreyBird Ventures?
Michael Devlin, Thomas Miller, and Scott Gazelle Ph.D are the founders of GreyBird Ventures.
-
Where is GreyBird Ventures headquartered?
GreyBird Ventures is headquartered in Concord, MA.
-
What is GreyBird Ventures's total asset value?
GreyBird Ventures has around 0000 in total assets under management.
-
How many investments has GreyBird Ventures made?
GreyBird Ventures has made 9 investments.
-
What has GreyBird Ventures invested in?
GreyBird Ventures has made numerous investments in companies like Genetika+, Platomics, and Angstrom within the Decision/Risk Analysis and Diagnostic Equipment industries.
-
What has GreyBird Ventures invested in recently?
GreyBird Ventures's latest investment was on 01-Nov-2021 in Genetika+, a company within the Decision/Risk Analysis industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
